Phagocytes transmit Chlamydia pneumoniae from the lungs to the vasculature

European Respiratory Journal

Volumn 23, Issue 4, 2004, Pages 506-510

  Gieffers, Jens ^a   van Zandbergen, G ^a   Rupp, J ^a   Sayk, F ^a   Kruger S ^a   Ehlers, S ^b   Solbach, W ^a   Maass, M ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b RESEARCH CENTER BORSTEL   (Germany)

Author keywords

Animal model; Chlamydia; Dissemination; Macrophages; Monocytes; Vascular infection

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTICLE; BACTERIUM DETECTION; BLOOD FLOW; BLOOD VESSEL WALL; CHLAMYDOPHILA PNEUMONIAE; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; DISEASE CARRIER; EPITHELIUM CELL; FEMALE; GRANULOCYTE; HOST CELL; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS EPITHELIUM; LUNG ALVEOLUS MACROPHAGE; LUNG BLOOD VESSEL; LYMPHATIC SYSTEM; LYMPHOID TISSUE; MONITORING; MONOCYTE; NONHUMAN; PHAGOCYTE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RABBIT; SPLEEN; SYSTEMIC CIRCULATION;

ANIMALS; AORTA; BACTEREMIA; BLOOD VESSELS; CAPILLARY PERMEABILITY; CELL MOVEMENT; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; FEMALE; GRANULOCYTES; LUNG; LYMPHOID TISSUE; MACROPHAGES, ALVEOLAR; MONOCYTES; PHAGOCYTES; PULMONARY ALVEOLI; RABBITS; RESPIRATORY TRACT INFECTIONS; SPLEEN;

EID: 1842481375     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.04.00093304     Document Type: Article

References (21)

1. Grayston JT. Infections caused by Chlamydia pneumoniae strain TWAR. Clin Infect Dis 1992; 15: 757-761.
2. Saikku P. Epidemiology of Chlamydia pneumoniae in atherosclerosis. Am Heart J 1999; 138: S500-S503.
3. Gieffers J, Pohl D, Treib J, et al. Presence of Chlamydia pneumoniae DNA in the cerebral spinal fluid is a common phenomenon in a variety of neurological diseases and not restricted to multiple sclerosis. Ann Neurol 2001; 49: 585-589.
4. Balin BJ, Gerard HC, Arking EJ, et al. Identification and localization of Chlamydia pneumoniae in Alzheimer's brain. Med Microbiol Immunol 1998; 187: 23-42.
5. Grayston JT, Campbell LA. The role of Chlamydia pneumoniae in atherosclerosis. Clin Infect Dis 1999; 28: 993-994.
6. Boman J, Soderberg S, Forsberg J, et al. High prevalence of Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in patients with cardiovascular disease and in middle-aged blood donors. J Infect Dis 1998; 178: 274-277.
7. Gieffers J, Fullgraf H, Jahn J, et al. Chlamydia pneumoniae infection in circulating human monocytes is refractory to antibiotic treatment. Circulation 2001; 103: 351-356.
8. Gaydos CA, Summersgill JT, Sahney NN, Ramirez JA, Quinn TC. Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells. Inject Immun 1996; 64: 1614-1620.
9. Moazed TC, Kuo CC, Grayston JT, Campbell LA. Evidence of systemic dissemination of Chlamydia pneumoniae via macrophages in the mouse. J Infect Dis 1998; 177: 1322-1325.
10. Maass M, Bartels C, Engel PM, Mamat U, Sievers HH. Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease. J Am Coll Cardiol 1998; 31: 827-832.
11. Dowell SF, Peeling RW, Boman J, et al. Standardizing Chlamydia pneumoniae assays: Recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). Clin Infect Dis 2001; 33: 492-503.
12. Maass M, Bartels C, Kruger S, Krause E, Engel PM, Dalhoff K. Endovascular presence of Chlamydia pneumoniae DNA is a generalized phenomenon in atherosclerotic vascular disease. Atherosclerosis 1998; 140: S25-S30.
13. Redecke V, Dalhoff K, Bohnet S, Braun J, Maass M. Interaction of Chlamydia pneumoniae and human alveolar macrophages: Infection and inflammatory response. Am J Respir Cell Mol Biol 1998; 19: 721-727.
14. Harmsen AG, Muggenburg BA, Snipes MB, Bice DE. The role of macrophages in particle translocation from lungs to lymph nodes. Science 1985; 230: 1277-1280.
15. Davidson M, Kuo CC, Middaugh JP, et al. Confirmed previous infection with Chlamydia pneumoniae (TWAR) and its presence in early coronary atherosclerosis. Circulation 1998; 98: 628-633.
16. Guidi Rontani C. The alveolar macrophage: The Trojan horse of Bacillus anthracis. Trends Microbiol 2002; 10: 405-409.
17. Kaul R, Uphoff J, Wiedeman J, Yadlapalli S, Wenman WM. Detection of Chlamydia pneumoniae DNA in CD3+ lymphocytes from healthy blood donors and patients with coronary artery disease. Circulation 2000; 102: 2341-2346.
18. Heinemann M, Susa M, Simnacher U, Marre R, Essig A. Growth of Chlamydia pneumoniae induces cytokine production and expression of CD14 in a human monocytic cell line. Infect Immun 1996; 64: 4872-4875.
19. Kaukoranta-Tolvanen SS, Teppo AM, Laitinen K, Saikku P, Linnavuori K, Leinonen M. Growth of Chlamydia pneumoniae in cultured human peripheral blood mononuclear cells and induction of a cytokine response. Microb Pathog 1996; 21: 215-221.
20. Fong IW, Chiu B, Viira E, Fong MW, Jang D, Mahony J. Rabbit model for Chlamydia pneumoniae infection. J Clin Microbiol 1997; 35: 48-52.
21. Moazed TC, Kuo C, Patton DL, Grayston JT, Campbell LA. Experimental rabbit models of Chlamydia pneumoniae infection. Am J Pathol 1996; 148: 667-676.